GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DaShenLin Pharmaceutical Group Co Ltd (SHSE:603233) » Definitions » EV-to-FCF

DaShenLin Pharmaceutical Group Co (SHSE:603233) EV-to-FCF : 8.61 (As of Jul. 22, 2025)


View and export this data going back to 2017. Start your Free Trial

What is DaShenLin Pharmaceutical Group Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, DaShenLin Pharmaceutical Group Co's Enterprise Value is ¥20,559 Mil. DaShenLin Pharmaceutical Group Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2025 was ¥2,389 Mil. Therefore, DaShenLin Pharmaceutical Group Co's EV-to-FCF for today is 8.61.

The historical rank and industry rank for DaShenLin Pharmaceutical Group Co's EV-to-FCF or its related term are showing as below:

SHSE:603233' s EV-to-FCF Range Over the Past 10 Years
Min: -1129.78   Med: 24.2   Max: 166.73
Current: 8.67

During the past 13 years, the highest EV-to-FCF of DaShenLin Pharmaceutical Group Co was 166.73. The lowest was -1129.78. And the median was 24.20.

SHSE:603233's EV-to-FCF is ranked better than
51.58% of 380 companies
in the Biotechnology industry
Industry Median: 9.65 vs SHSE:603233: 8.67

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-07-22), DaShenLin Pharmaceutical Group Co's stock price is ¥16.86. DaShenLin Pharmaceutical Group Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0.860. Therefore, DaShenLin Pharmaceutical Group Co's PE Ratio (TTM) for today is 19.60.


DaShenLin Pharmaceutical Group Co EV-to-FCF Historical Data

The historical data trend for DaShenLin Pharmaceutical Group Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DaShenLin Pharmaceutical Group Co EV-to-FCF Chart

DaShenLin Pharmaceutical Group Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 44.83 138.96 14.54 22.88 12.08

DaShenLin Pharmaceutical Group Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.11 12.02 14.39 12.08 8.40

Competitive Comparison of DaShenLin Pharmaceutical Group Co's EV-to-FCF

For the Biotechnology subindustry, DaShenLin Pharmaceutical Group Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DaShenLin Pharmaceutical Group Co's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, DaShenLin Pharmaceutical Group Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where DaShenLin Pharmaceutical Group Co's EV-to-FCF falls into.


;
;

DaShenLin Pharmaceutical Group Co EV-to-FCF Calculation

DaShenLin Pharmaceutical Group Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=20559.273/2389.107
=8.61

DaShenLin Pharmaceutical Group Co's current Enterprise Value is ¥20,559 Mil.
DaShenLin Pharmaceutical Group Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2,389 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DaShenLin Pharmaceutical Group Co  (SHSE:603233) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

DaShenLin Pharmaceutical Group Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=16.86/0.860
=19.60

DaShenLin Pharmaceutical Group Co's share price for today is ¥16.86.
DaShenLin Pharmaceutical Group Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.860.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


DaShenLin Pharmaceutical Group Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of DaShenLin Pharmaceutical Group Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


DaShenLin Pharmaceutical Group Co Business Description

Traded in Other Exchanges
N/A
Address
No. 410-1, Longxi Avenue, Liwan District, Guangdong Province, Guangzhou, CHN, 510000
DaShenLin Pharmaceutical Group Co Ltd is engaged in the pharmaceutical manufacturing, retail, and wholesale business. The company is based on the development of the pharmacy chain. It primarily offers Chinese herbal medicine such as antibiotics and biochemical drugs. The business activities are geographically carried out through China.

DaShenLin Pharmaceutical Group Co Headlines

No Headlines